Skip to main content
TITAN PHARMACEUTICALS INC logo

TITAN PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · TTNP ISIN · US8883146065 LEI · 549300NOUZGB2ZNVJ794 US Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2015-08-25 Declaration of Voting R…
Country US United States of America
Listing US TTNP

About TITAN PHARMACEUTICALS INC

https://www.titanpharm.com/

Titan Pharmaceuticals, Inc. is a development-stage biopharmaceutical company that develops proprietary therapeutics using its clinically proven ProNeura® technology, a long-term, continuous drug delivery platform. This platform is designed for the administration of medicines to treat select chronic diseases. The ProNeura system involves a small, solid implant that is placed subdermally and provides continuous, non-fluctuating blood levels of a drug for an extended period. The company's development efforts have historically focused on treatments for central nervous system disorders.

Recent filings

Filing Released Lang Actions
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 24, 2015, reporting the results of an annual meeting of stockholders. It details the voting outcomes on various matters including election of directors, approval of an omnibus incentive plan, reverse stock split, auditor ratification, executive compensation, and frequency of say-on-pay votes. The key section is Item 5.07, which is specifically about submission of matters to a vote of security holders. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual report, earnings release, or management discussion, but a current report focused on voting results. The length is about 5,055 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2015-08-25 English
FORM 10-Q
Interim / Quarterly Report Q2 2015
2015-08-13 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'DEFA14A' and references 'Schedule 14A' which is a definitive proxy statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes a supplement to the proxy statement for an annual meeting of stockholders, discussing voting procedures and a specific proposal (reverse stock split). The content is clearly related to proxy solicitation and information provided to shareholders to request votes for the meeting. The document length is 3538 characters, which is consistent with a proxy solicitation document rather than a full annual report or other financial report. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI).
2015-08-11 English
DEF 14A
Proxy Solicitation & Information Statement
2015-07-18 English
Regulatory Filings 2015
Regulatory Filings
2015-07-09 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm responding to a comment from the SEC staff regarding a preliminary proxy statement for Titan Pharmaceuticals, Inc. The content discusses disclosure revisions related to a planned reverse stock split and authorized but unissued shares. It references a 'preliminary proxy statement' and addresses SEC comments on disclosure adequacy. The document is short (2332 characters) and is clearly a correspondence related to regulatory review of a proxy statement, not the proxy statement itself or a full report. It does not contain financial data or the proxy materials themselves, but rather a response to SEC comments. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and correspondence with regulators that do not fit other categories.
2015-07-08 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.